Carson Wealth (CWM LLC)
CAMP icon

Carson Wealth (CWM LLC)’s CAMP4 Therapeutics CAMP Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5
Closed – – 5395
2025
Q3 		$0 Sell
5
-63
-93% -$117 ﹤0.01% 5288
2025
Q2 		$0 Sell
68
-192
-74% -$382 ﹤0.01% 5129
2025
Q1 		$1K Buy
+260
New +$1.26K ﹤0.01% 4871

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carson Wealth (CWM LLC)'s CAMP Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of CAMP4 Therapeutics (CAMP) in Q4 2025, closing a stake of 5 shares.

Carson Wealth (CWM LLC) first reported a position in CAMP in Q1 2025 and held it in 3 quarters. The position peaked at $1K in Q1 2025. 40 funds tracked by Wall St. Rank hold CAMP as of Q4 2025.

  • Carson Wealth (CWM LLC) reported no remaining CAMP4 Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 5 CAMP4 Therapeutics shares in Q4 2025.
  • Carson Wealth (CWM LLC) first reported a position in CAMP4 Therapeutics in Q1 2025 and held it in 3 quarters.
  • Carson Wealth (CWM LLC)'s CAMP4 Therapeutics position peaked at $1K in Q1 2025.
  • 40 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.